SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Quiroga Moreno Isidoro (Last) (First) (Middle) AVENIDA PRESIDENTE RIESCO 5711 OFICINA 1603, LAS CONDES (Street) SANTIAGO F3 7550000 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 07/29/2021	3. Issuer Name and Ticker or Trading Symbol Rani Therapeutics Holdings, Inc. [ RANI ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year) 07/29/2021
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	2,956,629(1)	I(1)	Shares indirectly held through South Lake One LLC(2)
Class A Common Stock	2,316,121(1)	I(1)	Shares indirectly held through Aequanimitas Limited Partnership(3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* Quiroga Moreno Isidoro (Last) (First) (Middle) AVENIDA PRESIDENTE RIESCO 5711 OFICINA 1603, LAS CONDES (Street) SANTIAGO F3 7550000 (City) (State) (Zip)

1. Name and Address of Reporting Person* South Cone Investments Limited Partnership (Last) (First) (Middle) AVENIDA PRESIDENTE RIESCO 5711 OFICINA 1603, LAS CONDES (Street) SANTIAGO F3 7550000 (City) (State) (Zip)

Explanation of Responses:

1. This amendment to Isidoro Quiroga Moreno's Form 3, originally filed with the SEC on July 29, 2021, is being filed to (i) correct the number of shares of Class A Common Stock of Rani Therapeutics Holdings, Inc. (the "Issuer") beneficially owned by Isidoro Quiroga Moreno, as set forth in Table I to the initial Form 3 filing, and (ii) to add an additional Reporting Person, South Cone Investments Limited Partnership ("South Cone"), the entity through which Isidoro Quiroga Moreno indirectly controls South Lake One LLC ("South Lake") and Aequanimitas Limited Partnership ("Aequanimitas"), which may be deemed an indirect beneficial owner of the reported securities and was omitted from the initial Form 3 filing.

2. Isidoro Quiroga Moreno indirectly controls South Lake, which has sole voting power and sole dispositive power with respect to all of the shares of the Issuer's Class A Common Stock held by it. South Lake is wholly owned by South Cone, which is controlled by its general partner Inversiones El Aromo Limitada ("El Aromo"), which is controlled by Isidoro Quiroga Moreno (who directly owns approximately 71% of the issued and outstanding capital stock of El Aromo).

3. Isidoro Quiroga Moreno indirectly controls Aequanimitas, which has sole voting power and sole dispositive power with respect to all of the shares of the Issuer's Class A Common Stock held by it. Aequanimitas is controlled by its general partner, South Lake Three LLC, which is wholly owned by South Cone, which is controlled by its general partner El Aromo, which is controlled by Isidoro Quiroga Moreno (who directly owns approximately 71% of the issued and outstanding capital stock of El Aromo).

Remarks:

This Form 3/A amends and restates in its entirety the Form 3 filed on July 29, 2021 for the sole purpose of correcting the number of shares of Class A Common Stock of the Issuer beneficially owned by the Reporting Persons and including South Cone as an additional Reporting Person.

	/s/ Isidoro Quiroga Moreno	08/03/2021
	/s/ Isidoro Quiroga Cortes; and /s/ Luis Felipe Correa Gonzalez, Managers of Inversiones El Aromo Limitada, as General Partner and on behalf of South Cone Investments Limited Partnership	08/03/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.